Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Kato, Ken Ichiro ^a   Takamura, Toshinari ^a   Takeshita, Yumie ^a   Ryu, Yasuji ^a   Misu, Hirofumi ^a   Ota, Tsuguhito ^a   Tokuyama, Kumpei ^b   Nagasaka, Shoichiro ^c   Matsuhisa, Munehide ^d   Matsui, Osamu ^a   Kaneko, Shuichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; INSULIN; INTRAMYOCELLULAR LIPID; LIPID; LIVER FAT; UNCLASSIFIED DRUG; GLUCOSE;

ADULT; ARTICLE; BIOELECTRICAL IMPEDANCE ANALYSIS; BODY COMPOSITION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAT MASS; FATTY LIVER; FEMALE; GLUCONEOGENESIS; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; IMPEDANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; LIPID ANALYSIS; LIPID STORAGE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PROTON NUCLEAR MAGNETIC RESONANCE; SKELETAL MUSCLE; ANTIBODY SPECIFICITY; ASIAN CONTINENTAL ANCESTRY GROUP; BIOSYNTHESIS; BLOOD; COMPLICATION; DIET RESTRICTION; JAPAN; LIVER; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOLOGY; REGRESSION ANALYSIS;

ADIPOSITY; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; JAPAN; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; ORGAN SPECIFICITY; REGRESSION ANALYSIS;

EID: 84898645515     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092170     Document Type: Article

References (40)

1. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850. (Pubitemid 33641605)
2. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, et al. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55: 2005-2023.
3. Takamura T, Misu H, Ota T, Kaneko S (2012) Fatty liver as a consequence and cause of insulin resistance: Lessons from type 2 diabetic liver. Endocr J 59: 745-763.
4. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470. (Pubitemid 29418240)
5. Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, et al. (2007) Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46: 1392-1403. (Pubitemid 350155521)
6. Nakamura S, Takamura T, Matsuzawa-Nagata N, Takayama H, Misu H, et al (2009) Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem 284: 14809-14818.
7. Jornayvaz FR, Shulman GI (2012) Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. Cell Metab 15: 574-584.
8. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273. (Pubitemid 36792858)
9. Takamura T, Misu H, Matsuzawa-Nagata N, Sakurai M, Ota T, et al. (2008) Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients. Obesity 16: 2601-2609.
10. Sakurai M, Takamura T, Ota T, Ando H, Akahori H, et al. (2007) Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease. J Gastroenterol 42: 312-317. (Pubitemid 46681707)
11. Uno K, Katagiri H, Yamada T, Ishigaki Y, Ogihara T, et al. (2006) Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312: 1656-1659. (Pubitemid 43902665)
12. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, et al. (2010) Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464: 1313-1319.
13. Misu H, Takamura T, Takayama H, Hayashi H, Matsuzawa-Nagata N, et al. (2010) A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab 12: 483-495.
14. Kotronen A, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H (2008) Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome. Diabetologia 51: 130-138. (Pubitemid 50003448)
15. D'Adamo E, Cali AM, Weiss R, Santoro N, Pierpont B, et al. (2010) Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 33: 1817-1822.
16. McPherson S, Jonsson JR, Cowin GJ, O'Rourke P, Clouston AD, et al. (2009) Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol 51: 389-397.
17. American Diabetes Association (2010) Standards of medical care in diabetes-2010. Diabetes Care 33: S11-S61.
18. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223. (Pubitemid 9249478)
19. Finegood DT, Bergman RN, Vranic M (1987) Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Diabetes 36: 914-924.
20. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al Nonalcoholic Steatohepatitis Clinical Research Network (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321. (Pubitemid 40770284)
21. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 9: 2467-2474. (Pubitemid 29420675)
22. Ryysy L, Häkkinen AM, Goto T, Vehkavaara S, Westerbacka J, et al. (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49: 749-758. (Pubitemid 30339990)
23. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, et al. (1999) Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276: E977-E989. (Pubitemid 29249618)
24. Wolfe R (1992) Radioactive and Stable-Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis. New York, Wiley-Liss.
25. Cobelli C, Toffolo G, Bier DM, Nosadini R (1987) Models to interpret kinetic data in stable isotope tracer studies. Am J Physiol 253: E551-E564.
26. Cobelli C, Mari A, Ferrannini E (1987) Non-steady state: error analysis of Steele's model and developments for glucose kinetics. Am J Physiol 252: E679-E689.
27. Lomonaco R, Ortiz-Lopez C, Orsak B, Finch J, Webb A, et al. (2011) Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. Hepatology 54: 837-845.
28. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30: 89-94. (Pubitemid 46052504)
29. Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, et al. (2007) Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 133: 496-506. (Pubitemid 47187337)
30. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, et al. (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52: 2461-2474. (Pubitemid 37210533)
31. Nagasaka S, Tokuyama K, Kusaka I, Hayashi H, Rokkaku K, et al. (1999) Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes 48: 1054-1060. (Pubitemid 29226352)
32. Yki-Järvinen H, Young AA, Lamkin C, Foley JE (1987) Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 79: 1713-1719. (Pubitemid 17117278)
33. Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, et al. (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48: 634-642. (Pubitemid 40591217)
34. Thamer C, Machann J, Bachmann O, Haap M, Dahl D, et al. (2003) Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 88: 1785-1791. (Pubitemid 36623405)
35. Kurioka S, Murakami Y, Nishiki M, Sohmiya M, Koshimura K, et al. (2002) Relationship between visceral fat accumulation and anti-lipolytic action of insulin in patients with type 2 diabetes mellitus. Endocr J 49: 459-464. (Pubitemid 34988237)
36. Iozzo P (2009) Viewpoints on the way to a consensus session: where does insulin resistance start? The adipose tissue. Diabetes Care (Suppl. 2): S168-S173.
37. Kim JK, Michael MD, Previs SF, Peroni OD, Mauvais-Jarvis F, et al. (2000) Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest 105: 1791-1797. (Pubitemid 30421760)
38. Flannery C, Dufour S, Rabøl R, Shulman GI, Petersen KF (2012) Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly. Diabetes 61: 2711-2717.
39. Newgard CB (2012) Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab 15: 606-614.
40. Misu H, Ishikura K, Kurita S, Takeshita Y, Ota T, et al. (2012) Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes. PLoS One 7: e34952. doi: 10.1371/journal.pone.0034952. Epub 2012 April 4. Technology